South and Central America Drug Discovery Informatics Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The South and Central America Drug Discovery Informatics Market size is expected to reach US$ 594.4 Million by 2031 from US$ 252.0 Million in 2024. The market is estimated to record a CAGR of 13.4% from 2025 to 2031.

Executive Summary and South and Central America Drug Discovery Informatics Market Analysis:

The South and Central America drug discovery informatics market remains in early stages; however, it shows accelerating growth in key markets. Brazil's Ministry of Health allocated R$6 billion for digital health transformation in 2023, including the development of bioinformatics capabilities at Fiocruz, Latin America's largest public health research institution. Argentina's National Scientific and Technical Research Council reports a 150% increase in computational biology publications since 2018. Chile's Corfo innovation agency has funded 15 AI-health startups through its TechHealth program. The region benefits from lower operational costs for computational research. It still faces challenges, including inconsistent internet infrastructure, with only 65% of the population having reliable broadband access and limited venture capital available for health tech. Recent collaborations between Brazilian research centers and European pharmaceutical companies suggest growing international interest in the region's informatics potential, particularly for tropical disease research.

South & Central America Drug Discovery Informatics Market: Strategic Insights

South and Central America Drug Discovery Informatics Market Segmentation Analysis:

• By Workflow, the South and Central America Drug Discovery Informatics Market is segmented into Discovery Informatics and Drug Development. The Discovery Informatics segment dominated the market in 2024.
• By Service, the South and Central America Drug Discovery Informatics Market is segmented into Sequence Analysis Platform, Molecular Modelling, Clinical Trial Data Management, Docking, and Others. The Sequence Analysis Platform segment dominated the market in 2024.
• By Solutions, the South and Central America Drug Discovery Informatics Market is segmented into Software and Services. The Software segment dominated the market in 2024.
• By End User, the South and Central America Drug Discovery Informatics Market is segmented into Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), and Others. The Pharmaceutical and Biotechnology Companies segment dominated the market in 2024.

South & Central America Drug Discovery Informatics Market Players Density: Understanding Its Impact on Business Dynamics

The South & Central America Drug Discovery Informatics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

South and Central America Drug Discovery Informatics Market Outlook

Cloud computing offers unparalleled advantages in data storage, processing power, and accessibility, enabling companies to handle vast and complex datasets critical for modern drug discovery without investing heavily in on-premises infrastructure. Furthermore, cloud platforms facilitate real-time data access and seamless collaboration across global teams, accelerating innovation cycles and reducing time to market. Cloud solutions support the integration of diverse data types-from genomic sequences to clinical trial results-allowing for comprehensive analysis and faster decision-making. The pay-as-you-go pricing models commonly associated with cloud services lower entry barriers for smaller firms and academic labs, democratizing access to advanced informatics capabilities.

Moreover, cloud providers continuously update their platforms to incorporate the latest security protocols, compliance certifications, and cutting-edge AI/ML tools. This reduces the operational burden on organizations and ensures that they benefit from state-of-the-art technology without significant internal resource allocation. The flexibility of cloud architecture supports rapid scaling during peak research periods, optimizing resource utilization and cost management.

Thus, the growing adoption of cloud-based solutions in the drug discovery informatics market presents a significant opportunity for pharmaceutical companies and research organizations seeking scalable, flexible, and cost-effective platforms.

South and Central America Drug Discovery Informatics Market Country Insights

By country, the South and Central America Drug Discovery Informatics Market is segmented into Brazil, Argentina, and the Rest of South and Central America. Brazil held the largest share in 2024.

Brazil is the largest pharmaceutical market in South America and a key driver of the region's drug discovery informatics market. The country's strong domestic pharmaceutical industry, coupled with its large and diverse population, makes it an attractive hub for both clinical trials and research and development activities. The Brazilian government is a major force in the market, with the publicly funded healthcare system (SUS) and various research foundations providing significant support for biomedical research. This is creating a demand for informatics solutions to manage and analyze complex data. The increasing prevalence of chronic diseases and the growing focus on biopharmaceuticals and biosimilars are further fueling market growth. For instance, the Brazilian government's pharmaceutical spending has been substantial, with the national health system spending approximately 10% of the country's GDP on healthcare.

South and Central America Drug Discovery Informatics Market Company Profiles

Some of the key players operating in the market include Dassault Systèmes SE, Eurofins Scientific SE, Charles River Laboratories International Inc, Jubilant Pharma Limited, Revvity Inc, Thermo Fisher Scientific Inc., Certera, Selvita, Collaborative Drug Discovery, Inc., and Illumina, Inc.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

South and Central America Drug Discovery Informatics Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise